Similar to ob/ob mice, DIO mice, which represent a more relevant model for obesity-driven metabolic disease, also displayed increased hepatic protein levels of Grp78 as well as ApoB after treatment with FGF1 (Fig. S6). Here, FGF1 is linked to metabolic disease.